‘We now know our enemy’: UBC study offers new hope for treating relapsed childhood leukemia

New therapies have dramatically improved survival rates among children with pediatric acute myeloid leukemia (pAML)—a cancer that starts in the blood-forming cells of the bone marrow. But in cases where the cancer returns, doctors, children and their families are faced with a new set of challenges.

Read more: https://www.med.ubc.ca/news/we-now-know-our-enemy-ubc-study-offers-new-hope-for-treating-relapsed-childhood-leukemia/